Watch the recorded webinar here.
Thank you to everyone who participated in the live event!
The DBS research field is evolving from the focal effects of stimulation on the target anatomical structure to its impact on distributed brain networks. This development is paralleled by the growth of the “connectome” in neuroimaging. This presentation discussed the tractography-based connectome approach applied to subcallosal cingulate DBS for treatment-resistant depression and ALIC DBS for OCD, as well as the prospective testing of the connectome approach in a new cohort of depression subjects.
Presented by Maxime Descoteaux, PhD
Human brain white matter is composed of approximately 100,000 miles of axons. Diffusion MRI is used to assess white matter non-invasively and quantitatively. This presentation discussed a novel push button solution for advanced tractography that goes beyond classical diffusion tensor imaging (DTI). Additionally, the validation, security, and quality management necessary for a tool such as ANDI to obtain FDA-clearance was also discussed.
Helen S. Mayberg, MD, Ki Sueng Choi, PhD, and Maxime Descoteaux, PhD hosted a live Q&A immediately following the presentations.
Click here to watch a recording of the webinar now!
Please note that this webinar is not affiliated with an ACCME Accredited program. In the event that speakers or their respective institutions derive financial benefits from their involvement in this webinar, it is important to clarify that such circumstances do not constitute a conflict of interest. The organizers aim to uphold transparency and ensure that any potential financial interests do not compromise the integrity and impartiality of the webinar content. The speakers for this GE HealthCare sponsored webinar have not been compensated for their participation or preparation by GEHC or OHBM.
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from prevention and screening, to diagnosis, treatment, therapy, and monitoring. We are an $18 billion business with 51,000 employees working to create a world where healthcare has no limits.